From March 30, these 17 anticancer drugs will be included in Hebei Medical Insurance

[China Pharmaceutical network industry trends 】It is reported that Hebei recently issued a notice that since November 30, Hebei will incorporate all 17 kinds of national negotiated drugs into the payment scope of "Hebei basic medical insurance, work injury insurance and maternity insurance drug catalogue (2017 transitional version)", according to the management of class B drugs, its medical insurance payment standard, limited payment scope, drug classification and dosage form shall be in accordance with the national regulations Regular execution This is also another city after Shanxi, Shanghai, Liaoning, Zhejiang, Beijing and other provinces and cities, including 17 anti-cancer drugs in the national health insurance negotiation According to the notice, in order to ensure the connection with the use policy of 36 kinds of negotiated drugs of the state last year, the proportion of individual payment in advance for 17 kinds of negotiated drugs of the state is still 20% in the whole province According to the industry, the 17 anti-cancer drugs included in the catalogue are all newly marketed drugs in recent years, with a long duration Through the strategic purchase of these innovative drugs by medical insurance, it can promote and promote pharmaceutical enterprises to increase R & D investment, so as to develop more and better innovative drugs, benefiting large patients The author has learned that 17 drugs included in the drug catalog include 12 solid tumor drugs and 5 blood tumor drugs, all of which are clinically necessary, effective and urgently needed by the insured, involving multiple cancer types such as non-small cell lung cancer, renal cancer, colorectal cancer, melanoma, lymphoma, etc These 17 anticancer drugs include azacitidine, nilotinib, pemetanase, ibotinib, cetuximab, regofinib, afatinib, enrotinib, oxitinib, clozatinib, serenitinib, acitinib, pezoparib, sunitinib, vimofinib, isazolomi and octreotide Among them, nilotini has been included in the reimbursement scope of Hebei medical insurance The notice points out that the overall planning area where the proportion of personal first out of pocket is higher than 20% should be adjusted to 20%, and the overall planning area where the proportion of personal first out of pocket is lower than 20% can maintain the original policy The payment standard stipulated by each overall planning area shall be valid until November 30, 2020, and shall be adjusted according to the relevant provisions of the national medical insurance payment standard after the expiration of the validity period During the validity period, if generic drugs (generic drugs) are listed, the payment standard of drugs adjusted by the state will be notified separately It is worth noting that in terms of strengthening the use management, the notice requires that the use of drugs be strictly regulated, and the drugs with high cost and large dosage should be monitored and analyzed to ensure the safety of medical insurance fund If the actual expenses incurred by the medical institutions in 2018 exceed the total control index of the medical insurance fund due to the policy reasons such as the inclusion of negotiated drugs in the catalogue, reasonable compensation shall be given at the end of the year for liquidation, and the rational use of negotiated drugs shall be comprehensively considered when formulating the total control index of the medical insurance fund in the next year It is understood that at present, many places control the total amount of medical insurance funds of medical institutions, and hospitals often cannot get extra compensation if the amount of medical insurance funds used exceeds the specified amount In this context, the National Medical Security Bureau requires all regions to take effective measures to ensure the supply and rational use of negotiated drugs It can be seen from Hebei's notice that Hebei will further strengthen the control and management of medical insurance fund in medical institutions Now it's a week away from 30 days It's believed that hospitals, pharmaceutical enterprises and patients in the overall planning areas of Hebei are ready.